OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Pathways: Cbl Proteins in Tumorigenesis and Antitumor Immunity—Opportunities for Cancer Treatment
Mariya Liyasova, Ke Ma, Stanley Lipkowitz
Clinical Cancer Research (2014) Vol. 21, Iss. 8, pp. 1789-1794
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Cellular signalling by primary cilia in development, organ function and disease
Zeinab Anvarian, Kirk Mykytyn, Saikat Mukhopadhyay, et al.
Nature Reviews Nephrology (2019) Vol. 15, Iss. 4, pp. 199-219
Open Access | Times Cited: 659

Rapid evolutionary response to a transmissible cancer in Tasmanian devils
Brendan Epstein, Menna E. Jones, Rodrigo Hamede, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 235

Ubiquitination and the Regulation of Membrane Proteins
Natalie Foot, Tanya L. Henshall, Sharad Kumar
Physiological Reviews (2016) Vol. 97, Iss. 1, pp. 253-281
Closed Access | Times Cited: 223

miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL
Yanbo Wang, Luxiao Chen, Zhenyu Wu, et al.
BMC Cancer (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 102

Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b)
Lixin Zhou, Jiamei Yang, Kuojun Zhang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 816-837
Closed Access | Times Cited: 9

GPCRs in Cancer: Protease-Activated Receptors, Endocytic Adaptors and Signaling
Aleena Arakaki, Wen‐An Pan, JoAnn Trejo
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 7, pp. 1886-1886
Open Access | Times Cited: 80

The Src-family Kinase Lyn in Immunoreceptor Signaling
Ben F. Brian, Tanya S. Freedman
Endocrinology (2021) Vol. 162, Iss. 10
Open Access | Times Cited: 52

Role of CBL Mutations in Cancer and Non-Malignant Phenotype
Davide Leardini, Daria Messelodi, Edoardo Muratore, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 839-839
Open Access | Times Cited: 29

IFT20 modulates ciliary PDGFRα signaling by regulating the stability of Cbl E3 ubiquitin ligases
F Schmid, Kenneth Bødtker Schou, Martin Juel Vilhelm, et al.
The Journal of Cell Biology (2017) Vol. 217, Iss. 1, pp. 151-161
Open Access | Times Cited: 57

Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma
Shiao‐Ya Hong, Yu-Rung Kao, Te‐Chang Lee, et al.
Cancer Research (2018) Vol. 78, Iss. 17, pp. 4984-4996
Open Access | Times Cited: 52

Exploring the potential of 3D Zernike descriptors and SVM for protein–protein interface prediction
Sebastian Daberdaku, Carlo Ferrari
BMC Bioinformatics (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 49

circ-0001454 alleviates asthma airway inflammation and remodeling via sponging miR-770-5p and regulating cbl-b
Ruobai Liu, Yilan Song, Zhiguang Wang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access

Detection of CSF1 rearrangements deleting the 3′ UTR in tenosynovial giant cell tumors
Julie Ho, Thomas Peters, Brendan C. Dickson, et al.
Genes Chromosomes and Cancer (2019) Vol. 59, Iss. 2, pp. 96-105
Closed Access | Times Cited: 41

Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
Stefanie H. Mueller, Alvina G. Lai, Maria Valkovskaya, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 12

A microglia clonal inflammatory disorder in Alzheimer’s Disease
Rocío Vicario, Stamatina Fragkogianni, Leslie Weber, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4

Insights into the role of derailed endocytic trafficking pathway in cancer: From the perspective of cancer hallmarks
Hongjie Guo, Chen Xi Zhou, Mingming Zheng, et al.
Pharmacological Research (2024) Vol. 201, pp. 107084-107084
Open Access | Times Cited: 4

A microglia clonal inflammatory disorder in Alzheimer’s disease
Rocío Vicario, Stamatina Fragkogianni, Leslie Weber, et al.
eLife (2025) Vol. 13
Open Access

E3-ubiquitin ligases and recent progress in osteoimmunology
Yosuke Asano, Yoshinori Matsumoto, Jun Wada, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10

Bufalin induces protective autophagy by Cbl‐b regulating mTOR and ERK signaling pathways in gastric cancer cells
Haiyan Qi, Xiujuan Qu, Jing Liu, et al.
Cell Biology International (2018) Vol. 43, Iss. 1, pp. 33-43
Closed Access | Times Cited: 29

Epigenetic Mechanisms Dictating Eradication of Cancer by Natural Killer Cells
Suresh Bugide, Radoslav Janoštiak, Narendra Wajapeyee
Trends in cancer (2018) Vol. 4, Iss. 8, pp. 553-566
Open Access | Times Cited: 27

MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma
Ce Li, Qian Dong, Xiaofang Che, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 25

MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells
Qian Dong, Ce Li, Xiaofang Che, et al.
Oncotarget (2016) Vol. 7, Iss. 50, pp. 82338-82353
Open Access | Times Cited: 24

E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy
Davood Jafari, Mohammad Javad Mousavi, Sanaz Keshavarz Shahbaz, et al.
Clinical & Experimental Immunology (2020) Vol. 204, Iss. 1, pp. 14-31
Open Access | Times Cited: 22

The Role of Membrane-Associated E3 Ubiquitin Ligases in Cancer
Xuankun Chen, Li Jiang, Zhesheng Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13

Page 1 - Next Page

Scroll to top